Latest News
December 23, 2015
Seattle Genetics and Bristol-Myers Squibb Announce Initiation of Phase 1/2 Clinical Trial of ADCETRIS® (Brentuximab Vedotin) in Combination with Opdivo® (Nivolumab) in Relapsed or Refractory Non-Hodgkin Lymphoma
December 18, 2015
Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare
December 17, 2015
BMS and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Enter Into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Program
Latest Events
Event year list
2019
2018
2017
2016
2015
2014
2013
2012
November 10, 2015
09:30 AM MST
Bristol-Myers Squibb at the Credit Suisse 24th Annual Healthcare Conference
Bristol-Myers Squibb at the Credit Suisse 24th Annual Healthcare Conference
View Presentation
(opens in new window)
(
PDF
)
October 27, 2015
11:30 AM EST
2015 Third Quarter Results
Press Release
Press Release
(opens in new window)
(
PDF
233 KB
)
Quarterly Package of Financial Information
(opens in new window)
(
Excel
804 KB
)
October 1, 2015
10:05 AM EST
Bristol-Myers Squibb to Present at the Leerink Immuno-Oncology Roundtable